Bicarbonate

Bicarbonate

SCHEMBL168512

CNC.O=C([O-])[O-].[K+].[K+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL28050626 0.91
Acetic Acid SCHEMBL4421429 0.87
Bicarbonate SCHEMBL3895350 0.80
Bicarbonate SCHEMBL852 0.80
Bicarbonate SCHEMBL1332143 0.80
Bicarbonate SCHEMBL2351948 0.80 CA4 (0.67)
Bicarbonate SCHEMBL119467 0.80
Bicarbonate SCHEMBL28420909 0.80 CA4 (0.67)
Bicarbonate SCHEMBL2275798 0.80 CA4 (0.67)
Potassium Ion SCHEMBL16589362 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424351-B1 ANTI-CANCER DRUGS, AND USES RELATING FOR MALIGNANT MELANOMA AND OTHER CANCERS KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LTD (IN) 2015-10-21 EP disclosed
US-8143237-B2 Anti-cancer drugs, and uses relating for malignant melanoma and other cancers KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LIMITED (US) 2012-03-27 US disclosed
EP-2424351-A1 ANTI-CANCER DRUGS, AND USES RELATING FOR MALIGNANT MELANOMA AND OTHER CANCERS Kasina Laila Innova Pharmaceuticals Private Ltd. (IN) 2012-03-07 EP disclosed
WO-2010125575-A1 ANTI-CANCER DRUGS, AND USES RELATING FOR MALIGNANT MELANOMA AND OTHER CANCERS KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LIMITED (IN) 2010-11-04 WO disclosed
US-20100272678-A1 ANTI-CANCER DRUGS, AND USES RELATING FOR MALIGNANT MELANOMA AND OTHER CANCERS KASINA LAILA INNOVA PHARMACEUTICALS PRIVATE LIMITE (IN) 2010-10-28 US disclosed